Evaluating urinary dysfunction in patients with CANVAS
Official title: Evaluation of Urinary Dysfunction in CANVAS Patients
Run by Centre Hospitalier Universitaire de Nice · NCT06817707 · Data updated 2026-11-12
This study is trying to see how common urinary problems are in people with CANVAS and if these issues are linked to their neurological symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Nice Academic / other |
| Locations | 3 sites (Nice, Alpes Maritimes and 2 other locations) |
| Status | Recruiting |
| Started | March 21, 2025 |
| Main results expected | March 2027 |
| Study ends | March 2027 |
| Registry record updated | March 26, 2025 |
| Trial ID | NCT06817707 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older with genetically confirmed CANVAS.
✕Probably not a fit
Patients with unrelated urological conditions or those who have undergone recent urological interventions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the prevalence of urinary symptoms in patients diagnosed with Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome (CANVAS). It will evaluate the incidence of urinary dysfunction and potential complications in the urinary system among these patients. The study will involve detailed neurological examinations, laboratory tests for renal function, dysautonomia assessments, and the use of urinary function questionnaires to analyze the relationship between neurological deficits and urinary symptoms.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and management of urinary dysfunction in CANVAS patients, improving their quality of life.
How similar studies have gone: While the specific evaluation of urinary dysfunction in CANVAS is novel, similar studies have shown that understanding comorbidities in neurological conditions can lead to improved patient care.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years old and more * genetic confirmation of CANVAS (presence of pathogenic penta nucleotide expansion in both alleles of the replication factor C subunit 1(RFC1) gene or pathological penta nucleotide expansion in the heterozygous state associated with a truncating mutation on the second allele of the RFC1 gene) * Able to undergo renovesical ultrasound and urinary flow measurement; * Having given informed consent in writing; * Negative pregnancy test for people on childbearing age; * Social security affiliated Exclusion Criteria: * Presenting another urological pathology of base, not related to CANVAS; * Having undergone a urological intervention within the 6 months preceding the screening visit; * Presenting a condition that is incompatible with the proper conduct of the study as determined by the physician; * Protected by law under guardianship or curators, or not able to participate in a clinical study pursuant to article L. 1121-16 of the French Public Health Code * Pregnant or breastfeeding women for women of childbearing age
Where it's running
-
Nice University Hospital
Nice, Alpes Maritimes, France Recruiting -
Montpellier University hospital
Montpellier, Hérault, France Not yet recruiting -
Lille University Hospital
Lille, Nord, France Not yet recruiting
Study contacts
- Study coordinator: Andra EZARU
- Email: ezaru.a@chu-nice.fr
- Phone: 04 92 03 96 55
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home-use Erchonia EVRL laser for temporary relief of idiopathic peripheral neuropathy foot pain
This study will test whether a home-use Erchonia EVRL laser can provide temporary relief of foot pain for adults with idiopathic peripheral neuropathy.
-
Personalized brain stimulation paired with cerebellar rehabilitation
This study tests whether 3 weeks of personalized transcranial direct current stimulation (tDCS) plus intensive rehabilitation improves balance, coordination, and related symptoms in people with cerebellar damage compared to sham stimulation.
-
Collecting clinical, nerve conduction, electromyography, and ultrasound data in adults with peripheral neuropathy
This project will see if collecting detailed clinical, nerve conduction, electromyography, and ultrasound data from adults with peripheral neuropathy during routine visits can improve understanding and care.
-
Blood microRNA markers for chemotherapy-related peripheral nerve damage in lung and colorectal cancer
This study will test whether levels of tiny blood molecules called microRNAs can predict how often and how badly patients with lung or colorectal cancer get nerve damage from certain chemotherapies.
-
Nerve effects of enfortumab vedotin in people with urothelial cancer
We will see how nerve testing and patient-reported symptoms change in adults with urothelial cancer who are starting enfortumab vedotin.
-
Transcutaneous pulsed radiofrequency for postherpetic neuralgia pain
This study will try a non-invasive pulsed radiofrequency treatment applied through the skin to reduce pain in adults with postherpetic neuralgia who have not responded to standard treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.